Heart and kidney hope: old diabetes drug tested for new Life-Saving role
NCT ID NCT07344922
Summary
This study tested whether a drug called dapagliflozin, originally for diabetes, could help protect the kidneys, improve anemia, and support heart health in adults with chronic kidney disease who do not have diabetes. About 100 participants were randomly assigned to take either the drug or a placebo pill daily for one year, alongside their usual care. Researchers measured changes in kidney function, blood health, and heart health to see if the drug provided benefits beyond standard treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Urology and Nephrology Center, Mansoura University
Al Mansurah, Dakahlia Governorate, 35511, Egypt
Conditions
Explore the condition pages connected to this study.